Abstract
Extremely low frequency electromagnetic radiation (ELF-EMR) is an omnipresent component of electricity, with a frequency of 3-30Hz, and wavelengths 3,450-5,996km long. We reviewed the scientific literature regarding pediatric health effects resulting from chronic exposure to ELF-EMR and compared these with the international safety standards. Articles published between 1980-2007 were identified using Medline, Cancerlite, Science Citation Index, and EMBASE. For the general population, the International Commission on Non-Ionizing Radiation Protection considers chronic exposure to magnetic fields lower than 100μT to be safe. However, even 0.3-0.4μT has been associated with an increased risk of acute lymphoblastic leukemia (ALL) in children. Although there is no experimental model to test the effects of ELF-EMR on organic systems, the Precautionary Principle is fundamental to the protection of children who are exposed to residential radiation doses higher than 0.3μT.
Keywords: Children, environmental risk, policies, electromagnetic fields, power lines
Current Pediatric Reviews
Title: Pediatric Health Effects of Chronic Exposure to Extremely Low Frequency Electromagnetic Fields
Volume: 5 Issue: 4
Author(s): Juan Antonio Ortega-Garcia, Marlene Martin, Enrique Navarro-Camba, Julia Garcia-Castell, Offie P. Soldin and Josep Ferris-Tortajada
Affiliation:
Keywords: Children, environmental risk, policies, electromagnetic fields, power lines
Abstract: Extremely low frequency electromagnetic radiation (ELF-EMR) is an omnipresent component of electricity, with a frequency of 3-30Hz, and wavelengths 3,450-5,996km long. We reviewed the scientific literature regarding pediatric health effects resulting from chronic exposure to ELF-EMR and compared these with the international safety standards. Articles published between 1980-2007 were identified using Medline, Cancerlite, Science Citation Index, and EMBASE. For the general population, the International Commission on Non-Ionizing Radiation Protection considers chronic exposure to magnetic fields lower than 100μT to be safe. However, even 0.3-0.4μT has been associated with an increased risk of acute lymphoblastic leukemia (ALL) in children. Although there is no experimental model to test the effects of ELF-EMR on organic systems, the Precautionary Principle is fundamental to the protection of children who are exposed to residential radiation doses higher than 0.3μT.
Export Options
About this article
Cite this article as:
Antonio Ortega-Garcia Juan, Martin Marlene, Navarro-Camba Enrique, Garcia-Castell Julia, P. Soldin Offie and Ferris-Tortajada Josep, Pediatric Health Effects of Chronic Exposure to Extremely Low Frequency Electromagnetic Fields, Current Pediatric Reviews 2009; 5 (4) . https://dx.doi.org/10.2174/157339609791317333
DOI https://dx.doi.org/10.2174/157339609791317333 |
Print ISSN 1573-3963 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6336 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Current Research on Opioid Receptor Function
Current Drug Targets Breastfeeding and Diabetes
Current Diabetes Reviews Pituitary Dysfunction as a Cause of Cardiovascular Disease
Current Pharmaceutical Design PCR Detection and Sequencing of <i>Trichomonas vaginalis</i> in Women with Suspected Vaginitis in Southwestern Iran
Infectious Disorders - Drug Targets COVID-19 Vaccines in Clinical Trials and their Mode of Action for Immunity against the Virus
Current Pharmaceutical Design New Clinical Perspectives of Hypolipidemic Drug Therapy in Severe Hypercholesterolemia
Current Medicinal Chemistry Personalized Treatment of Obsessive-Compulsive Disorder: Radiology, EEG, Pharmacogenetics and Biochemistry
Current Pharmacogenomics and Personalized Medicine The Role of Metabolism in Toxicity of Polycyclic Aromatic Hydrocarbons and their Non-genotoxic Modes of Action
Current Drug Metabolism Immunotherapeutic Options for Pediatric Malignancies
Current Immunology Reviews (Discontinued) Optimized High-Yield Purification of Obesity-Associated Melanocortin 4 Receptor
Protein & Peptide Letters Targeting Apoptosis Resistance in Rhabdomyosarcoma
Current Cancer Drug Targets Therapies of Hematological Malignancies: An Overview of the Potential Targets and Their Inhibitors
Current Chemical Biology Synthesis and Evaluation of Haloacetyl, α-Bromoacryloyl and Nitrooxyacetyl Benzo[b]furan and Benzo[b]thiophene Derivatives as Potent Antiproliferative Agents Against Leukemia L1210 and K562 Cells
Letters in Drug Design & Discovery Editorial (Hot Topic: Pharmacological Developments in Assisted Reproduction)
Current Drug Targets Mesenchymal Stem Cell as a Potential Therapeutic for Inflammatory Bowel Disease- Myth or Reality?
Current Stem Cell Research & Therapy Nitric Oxide Control of Proliferation in Nerve Cells and in Tumor Cells of Nervous Origin
Current Pharmaceutical Design Probiotics/Prebiotics in Viral Respiratory Infections: Implication for Emerging Pathogens
Recent Patents on Biotechnology New Insights into HLA-G and Inflammatory Diseases
Inflammation & Allergy - Drug Targets (Discontinued) Biochemistry and Neurobiology of Prosaposin: A Potential Therapeutic Neuro-Effector
Central Nervous System Agents in Medicinal Chemistry Anti-Diabetic Compounds and their Patent Information: An Update
Recent Patents on Inflammation & Allergy Drug Discovery